The article by Grober et al. 1 provides valuable clinical information regarding the two Food and Drug Administration-approved formulations of testosterone (T) gels, Androgel and Testim. The authors ...

THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (NasdaqGM:RPRX) today announced results from an exploratory, efficacy and safety study of its oral investigational product, enclomiphene ...

Prasco announced that it has partnered with Auxilium to launch the authorized generic version of Auxilium’s Testim (testosterone 1% gel) for the treatment of hypogonadism in adult males. Testim, a ...

CHESTERBROOK, Pa. — Auxilium Pharmaceuticals, a specialty biopharmaceutical company, on Wednesday announced that it has partnered with Prasco to debut the authorized generic form of Testim gel, which ...

Wider meaning of the 76 percent drop in first-quarter Testim sales related to the prospects for Testopel may not be simple, but Auxilium Pharmaceuticals Inc.'s former (a gel) is apparently on the ...

Testim, which delivered sales of $211.2 million last year, is under significant pressure with the product expected to post revenues of less than $85 million this year. Challenges being faced by Testim ...

With a goal of helping the aging population enjoy life to the fullest, Auxilium Pharmaceuticals Inc. filed for its initial public offering, hoping to raise $86.25 million. The Norristown, Pa.-based ...

June 19, 2006 — The European Commission has approved a new indication for trastuzumab infusion, allowing its use for the adjuvant treatment of early-stage HER2-positive breast cancer; Health Canada ...

Specialty biopharmaceutical company says sales of its testosterone replacement therapy gel are way down. Auxilium Pharmaceuticals Inc.’s stock price plunged by nearly 20 percent Wednesday after the ...

Auxilium Pharmaceuticals, Inc. and CPEX Pharmaceuticals, Inc. File Lawsuit Against Upsher-Smith Laboratories, Inc. for Infringement of Testim(R) Patent CPEX Pharmaceuticals Inc Auxilium ...

The ongoing class action lawsuit against several makers of testosterone medications hasn’t been going well for AbbVie—it has lost two cases so far—but the legal saga is playing out quite differently ...

The authors' are grateful to Dr Morgentaler and the editorial team of the International Journal of Impotence Research for their important insights into this research. A few points however require ...